AstraZeneca’s Durvalumab Treatment Receives Fast-Track Approval
The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.
Fast-Track Approval
The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.
